title: Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
authors.forename: Marco
authors.initials: M
authors.lastname: Tabone
authors.forename: Luca
authors.initials: L
authors.lastname: Vigano
authors.forename: Cristiana
authors.initials: C
authors.lastname: Laudi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Ferrero
authors.forename: Riccardo
authors.initials: R
authors.lastname: Pellerito
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Capussotti
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control* / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D004334:Drug Administration Schedule; D006801:Humans; D007457:Iodine Radioisotopes; D007459:Iodized Oil / Q000008:administration & dosage* / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000601:surgery*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*
chemical_list: D007457:Iodine Radioisotopes; D007459:Iodized Oil